Page 86 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors
P. 86
Chapter 5
20 15 10
5
0
0 5 10 15 20
Time (years)
1494 766 430 226 101
Number at risk
Figure 1A: Cumulative risk of invasive and in situ BC in the complete SGC-cohort (excluding patients with BC before SGC). The solid line represents observed and dashed line the population-expected cumulative risk (corrected for age of the SGC cohort).
20 15 10
5
0
0 5 10 15 20
Time (years)
2083 1503 982 571 246
Number at risk
84
Figure 1B: Cumulative risk of invasive and in situ BC in the complete SGPA-cohort (including patients with BC before SGPA). Solid line represents observed and dashed line the population-expected cumulative risk.
Cumulative risk of
in situ or invasive breast cancer (%)
Cumulative risk of
in situ or invasive breast cancer (%)
